138 related articles for article (PubMed ID: 36763128)
21. Nimbolide enhances the antitumor effect of docetaxel via abrogation of the NF-κB signaling pathway in prostate cancer preclinical models.
Zhang J; Jung YY; Mohan CD; Deivasigamani A; Chinnathambi A; Alharbi SA; Rangappa KS; Hui KM; Sethi G; Ahn KS
Biochim Biophys Acta Mol Cell Res; 2022 Dec; 1869(12):119344. PubMed ID: 36007677
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.
Kapur N; Mir H; Sonpavde GP; Jain S; Bae S; Lillard JW; Singh S
Cancer Lett; 2019 Jul; 454():1-13. PubMed ID: 30974114
[TBL] [Abstract][Full Text] [Related]
23. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
Sekino Y; Han X; Kawaguchi T; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Shiota M; Yasui W; Matsubara A
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412591
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells.
Sanchez-Hernandez ES; Ochoa PT; Suzuki T; Ortiz-Hernandez GL; Unternaehrer JJ; Alkashgari HR; Diaz Osterman CJ; Martinez SR; Chen Z; Kremsky I; Wang C; Casiano CA
Cells; 2023 Aug; 12(16):. PubMed ID: 37626856
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancer.
Pilling A; Kim SH; Hwang C
Prostate; 2022 Feb; 82(2):182-192. PubMed ID: 34672379
[TBL] [Abstract][Full Text] [Related]
26. Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis.
Xing Z; Li S; Xing J; Yu G; Wang G; Liu Z
Lab Invest; 2022 Jun; 102(6):602-612. PubMed ID: 35152275
[TBL] [Abstract][Full Text] [Related]
27. Coordinated action of hypoxia-inducible factor-1α and β-catenin in androgen receptor signaling.
Mitani T; Harada N; Nakano Y; Inui H; Yamaji R
J Biol Chem; 2012 Sep; 287(40):33594-606. PubMed ID: 22865883
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.
Li Y; Zhang D; Wang X; Yao X; Ye C; Zhang S; Wang H; Chang C; Xia H; Wang YC; Fang J; Yan J; Ying H
Sci Rep; 2015 Jul; 5():12495. PubMed ID: 26205124
[TBL] [Abstract][Full Text] [Related]
29. The role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancers.
Ranasinghe WK; Xiao L; Kovac S; Chang M; Michiels C; Bolton D; Shulkes A; Baldwin GS; Patel O
PLoS One; 2013; 8(1):e54251. PubMed ID: 23342109
[TBL] [Abstract][Full Text] [Related]
30. β‑catenin nuclear translocation induced by HIF‑1α overexpression leads to the radioresistance of prostate cancer.
Luo Y; Li M; Zuo X; Basourakos SP; Zhang J; Zhao J; Han Y; Lin Y; Wang Y; Jiang Y; Lan L
Int J Oncol; 2018 Jun; 52(6):1827-1840. PubMed ID: 29658569
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA SNHG12 promotes cell proliferation and activates Wnt/β-catenin signaling in prostate cancer through sponging microRNA-195.
Song J; Wu X; Ma R; Miao L; Xiong L; Zhao W
J Cell Biochem; 2019 Aug; 120(8):13066-13075. PubMed ID: 30945357
[TBL] [Abstract][Full Text] [Related]
32. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
33. Polysaccharides from Lentinus edodes prevent acquired drug resistance to docetaxel in prostate cancer cells by decreasing the TGF-β1 secretion of cancer-associated fibroblasts.
Zhang W; Tao N; Bai L
J Nat Med; 2023 Sep; 77(4):817-828. PubMed ID: 37354258
[TBL] [Abstract][Full Text] [Related]
34. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
Aldahl J; Mi J; Pineda A; Kim WK; Olson A; Hooker E; He Y; Yu EJ; Le V; Lee DH; Geradts J; Sun Z
J Biol Chem; 2020 Jan; 295(2):631-644. PubMed ID: 31819003
[TBL] [Abstract][Full Text] [Related]
35. LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p.
Jiang X; Guo S; Zhang Y; Zhao Y; Li X; Jia Y; Xu Y; Ma B
Cell Signal; 2020 Jan; 65():109422. PubMed ID: 31672604
[TBL] [Abstract][Full Text] [Related]
36. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
[TBL] [Abstract][Full Text] [Related]
37. The Role of Crosstalk between AR3 and E2F1 in Drug Resistance in Prostate Cancer Cells.
Xu J; Yang X; Deshmukh D; Chen H; Fang S; Qiu Y
Cells; 2020 Apr; 9(5):. PubMed ID: 32354165
[TBL] [Abstract][Full Text] [Related]
38. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.
Liu H; Song X; Hou J; Zhao Z; Chang J
DNA Cell Biol; 2018 Mar; 37(3):210-219. PubMed ID: 29327946
[TBL] [Abstract][Full Text] [Related]
39. Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition.
Tamaki H; Harashima N; Hiraki M; Arichi N; Nishimura N; Shiina H; Naora K; Harada M
Oncotarget; 2014 Nov; 5(22):11399-412. PubMed ID: 25333266
[TBL] [Abstract][Full Text] [Related]
40. HIF1α expression under normoxia in prostate cancer--which pathways to target?
Ranasinghe WK; Baldwin GS; Bolton D; Shulkes A; Ischia J; Patel O
J Urol; 2015 Mar; 193(3):763-70. PubMed ID: 25444956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
